POSTERS
The cost-effectiveness of Axicabtagene Ciloleucel versus standard of care as second-line therapy in patients with large B-cell lymphoma in AUSTRALIA
LHC Author: Michael Aristides
Cost-effectiveness analysis of arthroscopic injection of a bioadhesive hydrogel implant in conjunction with microfracture for the treatment of focal chondral defects of the knee – an Australian perspective
LHC Author: George Papadopoulos
Cost Utility and Budget Impact Analyses of Closed Loop Upper Airway Stimulation (UAS) for the Treatment of Moderate to Severe Obstructive Sleep Apnea from an Australian Health Care System Perspective
LHC Author: George Papadopoulos
An IQVIA Business
Contact Us
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations. Learn more at www.iqvia.com
ADDRESS
Level 8,141 Walker Street, North Sydney, NSW, 2060
PHONE
GET IN TOUCH
Privacy Policy
Your Privacy Choices